Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Arunkumar Mohan"'
Autor:
Lisha K. Poonacha, Rashmi Ramesh, Akshay Ravish, Arunkumar Mohan, Pradeep M. Uppar, Prashant K. Metri, Nanjunda Swamy Shivananju, Santosh L. Gaonkar, Shubha Gopal, Alexey Yu Sukhorukov, Vijay Pandey, Priya Babu Shubha, Basappa Basappa
Publikováno v:
Applied Microbiology, Vol 3, Iss 4, Pp 1214-1228 (2023)
Heterocyclic compounds can specifically regulate bacterial development by targeting specific bacterial enzymes and metabolic pathways. The ESKAPE pathogens are multidrug-resistant and cause nosocomial infections, which is one of the greatest challeng
Externí odkaz:
https://doaj.org/article/9b33de861b99471ab32c0f9333821a16
Autor:
Akshay Ravish, Bhanuprakash C. Narasimhachar, Zhang Xi, Divakar Vishwanath, Arunkumar Mohan, Santosh L. Gaonkar, Paduvalahippe Gowdegowda Chandrashekara, Kwang Seok Ahn, Vijay Pandey, Peter E. Lobie, Basappa Basappa
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2716 (2023)
Nuclear factor kappa B (NF–κB) is a potential therapeutic target in breast cancer. In the current study, a new class of oxazine– and piperazine–linked pyrimidines was developed as inhibitors of NF–κB, overcoming the complexity of the oxazin
Externí odkaz:
https://doaj.org/article/49bccdd32cb44f69a849705e72eaa491
Autor:
Divakar Vishwanath, Zhang Xi, Akshay Ravish, Arunkumar Mohan, Shreeja Basappa, Niranjan Pattehalli Krishnamurthy, Santosh L. Gaonkar, Vijay Pandey, Peter E. Lobie, Basappa Basappa
Publikováno v:
Molecules, Vol 28, Iss 13, p 5254 (2023)
Histone deacetylases (HDACs) are an attractive drug target for the treatment of human breast cancer (BC), and therefore, HDAC inhibitors (HDACis) are being used in preclinical and clinical studies. The need to understand the scope of the mode of acti
Externí odkaz:
https://doaj.org/article/c54b1b27bfd644289ee40ca0d2e12c5f
Autor:
Basappa, Divakar Vishwanath, Zhang Xi, Akshay Ravish, Arunkumar Mohan, Shreeja Basappa, Niranjan Pattehalli Krishnamurthy, Santosh L. Gaonkar, Vijay Pandey, Peter E. Lobie, Basappa
Publikováno v:
Molecules; Volume 28; Issue 13; Pages: 5254
Histone deacetylases (HDACs) are an attractive drug target for the treatment of human breast cancer (BC), and therefore, HDAC inhibitors (HDACis) are being used in preclinical and clinical studies. The need to understand the scope of the mode of acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::2f7adc17f20c478d91d04b3a324c1fb1
Autor:
Venugopal, Vaishali C., Latha, K. C., Kishor, M., Arunkumar, Mohan, Venugopal, Vinitha, Balasubramanian, S.
Publikováno v:
Medical Journal of Dr. D.Y. Patil Vidyapeeth; Nov/Dec2023, Vol. 16 Issue 6, p864-871, 8p
Autor:
Praveen K Sharma, Arunkumar Mohanakrishnan, Aashika Parveen Amir, Aadithiyan Sekar, Sanjeedha Saliha Amir
Publikováno v:
Radiology Case Reports, Vol 19, Iss 9, Pp 3732-3739 (2024)
Ovarian lymphangiomas are rare benign neoplasms characterized by the proliferation of lymphatic vessels within the ovarian tissue. While lymphangiomas can manifest in various anatomical locations, their occurrence within the ovaries is exceptionally
Externí odkaz:
https://doaj.org/article/511ba8df294f4d13b1b7fe5f59c065b5
Autor:
Bodaghi, Abasalt1 abasalt.bodaghi@gmail.com, Arunkumar, Mohan2 annarun2002@yahoo.co.in, Sathya, Elumalai3 sathya24mathematics@gmail.com
Publikováno v:
Tbilisi Mathematical Journal. 2018, Vol. 11 Issue 2, p77-96. 20p.